Wrap (WRAP) 10-K 2 Mar 23 2022 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2022	Feb. 28, 2023	Jun. 30, 2022
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	000-55838
Entity Registrant Name	Wrap Technologies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-0551945
Entity Address, Address Line One	1817 W 4th Street
Entity Address, City or Town	Tempe
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85281
City Area Code	800
Local Phone Number	583-2652
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	WRAP
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 76,245,419
Entity Common Stock, Shares Outstanding (in shares)		41,256,885
Auditor Firm ID	89
Auditor Name	Rosenberg Rich Baker Berman, P.A.
Auditor Location	Somerset, New Jersey
Entity Central Index Key	0001702924
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 5,330	$ 4,937
Short-term investments	13,949	29,983
Accounts receivable and contract assets, net	2,830	3,859
Inventories, net	3,975	1,566
Prepaid expenses and other current assets	775	868
Total current assets	26,859	41,213
Property and equipment, net	758	976
Operating lease right-of-use asset, net	285	51
Intangible assets, net	2,569	1,982
Other assets	100	9
Total assets	30,571	44,231
Current liabilities:
Accounts payable	1,419	1,779
Accrued liabilities	1,463	824
Customer deposits	0	43
Deferred revenue- short term	166	155
Operating lease liability - short term	108	56
Total current liabilities	3,156	2,857
Long-term liabilities:
Deferred revenue- long term	167	110
Operating lease liability - long term	193	0
Total long-term liabilities	360	110
Total liabilities	3,516	2,967
Commitments and contingencies (Note 9 and 13)
Stockholders' equity:
Preferred stock - 5,000,000 authorized; par value $0.0001 per share; none issued and outstanding	0	0
Common stock - 150,000,000 authorized; par value $0.0001 per share; 41,175,993 and 40,851,945 shares issued and outstanding each period, respectively	4	4
Additional paid-in capital	94,333	91,025
Accumulated deficit	(67,376)	(49,759)
Accumulated other comprehensive loss	94	(6)
Total stockholders' equity	27,055	41,264
Total liabilities and stockholders' equity	$ 30,571	$ 44,231

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Preferred Stock, Shares Authorized (in shares)	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Issued (in shares)	0	0
Preferred Stock, Shares Outstanding, Ending Balance (in shares)	0	0
Common Stock, Shares Authorized (in shares)	150,000,000	150,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001	$ 0.0001
Common Stock, Shares, Issued (in shares)	41,175,993	40,851,945
Common Stock, Shares, Outstanding, Ending Balance (in shares)	41,175,993	40,851,945

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Product sales	$ 7,481	$ 7,381
Other revenue	568	348
Total revenues	8,049	7,729
Cost of revenues
Products and services	4,315	4,987
Product line exit expense	0	747
Total cost of revenues	4,315	5,734
Gross profit	3,734	1,995
Operating expenses:
Selling, general and administrative	16,386	20,276
Research and development	5,078	6,214
Total operating expenses	21,464	26,490
Loss from operations	(17,730)	(24,495)
Other income (expense):
Investment income	52	31
Other	61	15
Nonoperating Income (Expense), Total	113	46
Net loss	$ (17,617)	$ (24,449)
Net loss per basic and diluted common share (in dollars per share)	$ (0.43)	$ (0.62)
Weighted average common shares used to compute net loss per basic and diluted common share (in shares)	41,174,812	39,281,620
Comprehensive loss:
Net loss	$ (17,617)	$ (24,449)
Net unrealized gain (loss) on short-term investments	100	(21)
Comprehensive loss	$ (17,517)	$ (24,470)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member] Warrants at $6.50 Per Share [Member]	Common Stock [Member] Warrants at $8.125 Per Share [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Warrants at $6.50 Per Share [Member]	Additional Paid-in Capital [Member] Warrants at $8.125 Per Share [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Warrants at $6.50 Per Share [Member]	Retained Earnings [Member] Warrants at $8.125 Per Share [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member] Warrants at $6.50 Per Share [Member]	AOCI Attributable to Parent [Member] Warrants at $8.125 Per Share [Member]	AOCI Attributable to Parent [Member]	Warrants at $6.50 Per Share [Member]	Warrants at $8.125 Per Share [Member]	Total
Balance			$ 4			$ 71,705			$ (25,310)			$ 15			$ 46,414
Balance (in shares) at Dec. 31, 2020			37,554,162
Balance at Dec. 31, 2020			$ 4			71,705			(25,310)			15			46,414
Common shares issued upon exercise of warrants (in shares)	1,661,320	153,692
Common shares issued upon exercise of warrants	$ 0	$ 0		$ 10,798	$ 1,249		$ 0	$ 0		$ 0	$ 0		$ 10,798	$ 1,249
Common shares issued upon exercise of stock options (in shares)			915,404
Common shares issued upon exercise of stock options			$ 0			1,678			0			0			1,678
Common shares issued upon vesting of restricted stock units (in shares)			524,491
Common shares issued upon vesting of restricted stock units			$ 0			0			0			0			0
Common shares issued for services (in shares)			42,876
Common shares issued for services			$ 0			239			0			0			239
Share-based compensation expense			0			5,356			0			0			5,356
Net unrealized gain (loss) on short-term investments			0			0			0			(21)			(21)
Net loss			0			0			(24,449)			0			(24,449)
Net loss for the period			$ 0			0			(24,449)			0			(24,449)
Balance (in shares) at Dec. 31, 2021			40,851,945
Balance			$ 4			91,025			(49,759)			(6)			41,264
Balance at Dec. 31, 2021			$ 4			91,025			(49,759)			(6)			$ 41,264
Common shares issued upon exercise of stock options (in shares)			55,500												55,500
Common shares issued upon exercise of stock options			$ 0			83			0			0			$ 83
Common shares issued upon vesting of restricted stock units (in shares)			268,548
Common shares issued upon vesting of restricted stock units			$ 0			0			0			0			0
Share-based compensation expense			0			3,225			0			0			3,225
Net unrealized gain (loss) on short-term investments			0			0			0			100			100
Net loss			0			0			(17,617)			0			(17,617)
Net loss for the period			$ 0			0			(17,617)			0			(17,617)
Balance (in shares) at Dec. 31, 2022			41,175,993
Balance			$ 4			$ 94,333			$ (67,376)			$ 94			$ 27,055

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Parentheticals)	Dec. 31, 2021 $ / shares
Warrants at $6.50 Per Share [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 6.50
Warrants at $8.125 Per Share [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 8.125

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows From Operating Activities:
Net loss	$ (17,617)	$ (24,449)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	762	478
Share-based compensation	3,225	5,356
Common shares issued for services	0	239
Product line exit expense	0	747
Gain on sale of assets	0	(27)
Warranty provision	210	10
Software impairment charge	0	170
Change in contingent liability	0	(23)
Non-cash lease expense	101	88
Provision for doubtful accounts	72	123
Changes in assets and liabilities:
Accounts receivable	957	(2,111)
Inventories	(2,410)	559
Prepaid expenses and other current assets	93	(109)
Accounts payable	(360)	546
Operating lease liability	(91)	(94)
Customer deposits	(43)	41
Accrued liabilities and other	611	(54)
Warranty settlement	(181)	38
Deferred revenue	68	249
Net cash used in operating activities	(14,603)	(18,223)
Cash Flows From Investing Activities:
Purchase of short-term investments	(30,466)	(55,014)
Proceeds from maturities of short-term investments	46,600	50,005
Capital expenditures for property and equipment	(256)	(995)
Proceeds from long-term deposits	(92)
Proceeds from long-term deposits		4
Net cash provided by (used in) investing activities	14,913	(6,937)
Cash Flows From Financing Activities:
Proceeds from exercise of warrants	0	12,047
Proceeds from exercise of stock options	83	1,678
Repayment of debt	0	(275)
Net cash provided by financing activities	83	13,450
Net (decrease) increase in cash and cash equivalents	393	(11,710)
Cash and cash equivalents, beginning of period	4,937	16,647
Cash and cash equivalents, end of period	5,330	4,937
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Change in unrealized gain on short-term investments	100	(21)
Right-of-use asset and liability recorded during period	234	0
Patents and Trademarks [Member]
Cash Flows From Investing Activities:
Investment in patents and trademarks	(173)	(187)
Intangibles Other than Patents and Trademarks [Member]
Cash Flows From Investing Activities:
Investment in patents and trademarks	$ (700)	$ (750)

Note 1 - Organization and Summa

Note 1 - Organization and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization and Business Description Wrap Technologies, Inc., a Delaware corporation (the “ Company we us our Common Stock Nasdaq Principles of Consolidation The Company has one VR Basis of Presentation and Use of Estimates The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the US of America (“ US GAAP Concentrations of Risk Credit Risk Concentrations of Accounts Receivable and Revenue Concentration of Suppliers Impact of COVID-19 ( COVID-19 Cash and Cash Equivalents The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in Money Market Funds and US (“ US Short-Term Investments The Company’s short-term investments consist of US Treasury bills with original maturities beyond three months at the date of purchase and one year or less from the balance sheet date. As of December 31, 2021, all of the Company’s short-term investments were classified as available-for-sale and are carried at estimated fair value with any unrealized gains and losses, unrelated to credit loss factors, included in other comprehensive income in our consolidated statements of stockholders’ equity. Share-Based Compensation The Company follows the fair value recognition provisions issued by the FASB in ASC Topic 718, Stock Compensation (“ ASC 718 ASU Loss per Share Basic loss per common share is computed by dividing net loss for the period by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net loss per common share reflects the potential dilution of securities that could share in the earnings of an entity. The Company’s losses for the periods presented cause the inclusion of potential Common Stock instruments outstanding to be antidilutive. Stock options and restricted stock units exercisable or issuable for a total of 6,413,546 and 5,596,853 shares of Common Stock were outstanding at December 31, 2022 and 2021, respectively. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company. Accounts Receivable and Allowance for Credit Losses ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326) At December 31, 2022 and 2021, the Company had an allowance for credit losses related to accounts receivable of $205 and $134, respectively. If a major customer’s creditworthiness deteriorates, or actual defaults exceed our historical experience, such estimates could change and impact our future reported financial results. Inventories Inventories are valued at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventory is comprised of raw materials, assemblies and finished products intended for sale to customers . At December 31, 2022 and 2021 the Company had no reserve for obsolescence. Property, Equipment and Depreciation Property and equipment is stated at cost. Depreciation on property and equipment is computed over the estimated useful lives of three years using the straight-line method. On any retirement or disposition of property and equipment, the related cost and accumulated depreciation or amortization is removed, and a gain or loss recorded. Business Combinations Transactions in which the Company obtains control of a business are accounted for according to the acquisition method as described in ASC 805, Business Combinations. The assets acquired and liabilities assumed are recognized and measured at their fair values as of the date control is obtained. The Company measures goodwill as the excess of consideration transferred, which the Company also measures at fair value, over the net of the acquisition date amounts of the identifiable assets acquired and liabilities assumed. Acquisition related costs in connection with a business combination are expensed as incurred. Contingent consideration is recognized and measured at fair value at the acquisition date and until paid is re-measured on a recurring basis and classified as a liability. Intangible Assets Intangible assets consist of (a) capitalized legal fees and filing costs related to obtaining patents and trademarks, (b) tradenames and software, (c) purchased software, and (d) the purchase cost of indefinite-lived website domains. The estimated useful lives of identifiable intangible assets with definite useful lives have been estimated to be between one and twenty years. Purchased website domain costs with an indefinite useful life are not subject to amortization, but are subject to an annual impairment test, by comparing their carrying amount with their corresponding fair value. For any given intangible asset with an indefinite useful life, if its fair value exceeds its carrying amount no impairment loss shall be recognized. The carrying value of intangibles is periodically reviewed and impairments, if any, are recognized when the future undiscounted cash flows realized from the assets is less than its carrying value. Impairment of Long-Lived Assets Long-lived assets and identifiable intangibles held for use are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If the sum of undiscounted expected future cash flows is less than the carrying amount of the asset or if changes in facts and circumstances indicate, an impairment loss is recognized and measured using the asset’s fair value. The Company did not recognize any other impairment loss during the years ended December 31, 2022 and 2021. Classification and Valuation of Warrants The Company accounts for warrants as either equity or liabilities based upon the characteristics and provisions of each particular instrument. Warrants valued and classified as equity are recorded as additional paid-in capital based on the issue date fair value and no further adjustment to valuation is made. As of December 31, 2022, the Company has no warrants or other derivative financial instruments that require separate accounting as liabilities and periodic revaluation. Advertising and Promotion Costs Advertising costs are charged to expense as incurred and were $426 and $145 for the years ended December 31, 2022 and 2021, respectively. The Company also incurred product promotion costs for demonstration products delivered to prospective customers of $688 and $924 for the years ended December 31, 2022 and 2021, respectively. Advertising and promotion costs are included in selling, general and administrative expenses in the accompanying statements of operations. Demonstration and Training Costs The Company maintains a demonstration and training department as a part of its sales and marketing activities and does not charge for product demonstrations or training. Training is not a condition or requirement of sale as most sales are made through distributors to their end customers. The Company conducts local and regional in-person, webinar and on-line demonstrations and use of force and escalation training to support law enforcement agencies with no purchase requirement. Such training, when provided, may occur before or after initial or subsequent purchase or field deployment of the Company’s products. The Company believes that law enforcement trainers and officers that have seen demonstrations or have been trained about its products are more supportive of their departments purchase and deployment of product. Research and Development Costs Research and development costs are expensed as incurred. Contract Manufacturers The Company employs contract manufacturers for production of certain components and sub-assemblies. The Company may provide parts and components to such parties from time to time but recognizes no revenue or markup on such transactions. Leases The Company adopted ASC Topic 842, Leases (“ Topic 842 Revenue Recognition The Company adopted ASC Topic 606, Revenue from Contracts with Customers on January 1, 2018. The Company enters into contracts that include various combinations of products, accessories, software and services, each of which are generally distinct and are accounted for as separate performance obligations. Product sales include BolaWrap products and accessories. Other revenue includes VR revenues, service, training and shipping revenues. A performance obligation is a promise in a contract to transfer a distinct good or service to a customer and is the unit of account in Topic 606. For contracts with a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts with multiple performance obligations, the Company allocates the contract transaction price to each performance obligation using the Company’s estimate of the standalone selling price (“ SSP SSPs Most of the Company’s products and accessories are sold through domestic and international distributors. Performance obligations to deliver products and accessories are generally satisfied at the point in time the Company ships the product, as this is when the customer obtains control of the asset under our standard terms and conditions. Periodically, certain customers request bill and hold transactions for future delivery as scheduled and designated by them. In such cases, revenue is not recognized until after control, title and risk of ownership has transferred which is generally when the customer has requested such transaction under normal billing and payment terms and has been notified that the product (i) has been completed according to customer specifications, (ii) has passed quality control inspections, and (iii) has been tagged and packed for shipment, separated from other inventory and ready for physical transfer to the customer. The value associated with custodial storage services is deemed immaterial in the context of such contracts and in total, and accordingly, none of the transaction price is allocated to such service. The Company has elected to recognize shipping costs as an expense in cost of revenue when control has transferred to the customer. Time-based VR system contracts generally include setup, training and the use of software and hardware for a fixed term, generally one to five years and support and upgrade services during the same period. The Company does not sell time-based arrangements without setup, training and support services and therefore revenues for the entire arrangement are recognized on a straight-line basis over the term. When hardware is bundled and not sold separately the Company allocates the contract transaction price to each performance obligation using the SSP of each distinct good and service in the contract. The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced, and a receivable is recorded. A contract asset is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company may receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. Estimated costs for the Company’s standard warranty, generally one-year, are charged to cost of products sold when revenue is recorded for the related product. Royalties are also charged to cost of products sold. Shipping and Handling Costs Shipping and handling costs are included in cost of revenues. Shipping and handling costs invoiced to customers are included in revenue. Actual shipping and handling costs were $296 and $167 for the years ended December 31, 2022 and 2021, respectively. Actual revenues from shipping and handling were $109 and $88 for the years ended December 31, 2022 and 2021, respectively. Exit Activity Expense During 2021 the Company recorded $747 of product line exit costs related to the wind down and closure of the BolaWrap 100 product line related to a shift in production efforts to a new BolaWrap 150 generation product requiring new tooling, new production equipment and processes and additional licensing. These non-cash inventory costs included end of life raw material write offs of $641 and tooling retirement costs of $106. The $747 of exit costs were recorded as a component of cost of revenues. There was no such expense recorded during the year ended December 31, 2022. Development and start-up expense of new products are expensed as incurred except for capitalized equipment and tooling. Warranty Reserves The Company warrants its products and accessories to be free from defects in materials and workmanship for a period of one year from the date of purchase. The warranty is generally limited. The Company currently provides direct warranty service. International market warranties are generally similar to the US market. The Company establishes a warranty reserve based on anticipated warranty claims at the time product revenues are recognized. Factors affecting warranty reserve levels include the number of units sold, anticipated cost of warranty repairs and anticipated rates of warranty claims. The Company evaluates the adequacy of the provision for warranty costs each reporting period. The warranty reserve was $125 and $96 at December 31, 2022 and 2021. Actual warranty costs could differ from estimates. Segment Information ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Income Taxes No income tax expense was recorded for the periods ended December 31, 2022 and 2021 due to losses incurred. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimates. Recently Issued Accounting Guidance In October 2021 , FASB ASU Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ASU 2021-08 ASC , Revenue from Contracts with Customers Topic 606 , The Company has reviewed other recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.

Note 2 - Revenue and Product Co

Note 2 - Revenue and Product Costs	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	2. REVENUE AND PRODUCT COSTS Revenues consist of product revenue and other revenue. Product sales include BolaWrap products and accessories. Other revenue includes VR revenues, service, training and shipping revenues. The table below details the activity in our contract liabilities during the year ended December 31, 2022. Customer Deferred Deposits Revenue Balance at January 1, 2022 $ 43 $ 265 Additions, net - 301 Transfer to revenue (43 ) (233 ) Balance at December 31, 2022 $ - $ 333 Current portion $ - $ 166 Long-term portion $ - $ 167 At December 31, 2022, the Company’s deferred revenue of $333 thousand of deferred revenue at December 31, 2022, of which $198 thousand related to VR, $11 thousand was related to training and $124 thousand related to BolaWrap extended warranties and services. At December 31, 2021, the Company’s deferred revenue of $265 consisted of $172 related to VR training and $67 related to extended warranties and services. The Company recognizes an asset if there are incremental costs of obtaining a contract with a customer such as commissions. These costs are ascribed to or allocated to the underlying performance obligations in the contract and amortized consistent with the recognition timing of the revenue for any such underlying performance obligations. The Company had no .

Note 3 - Asset Acquisition

Note 3 - Asset Acquisition	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Business Combination Disclosure [Text Block]	3. ASSET ACQUISITION On November 22, 2022, Wrap Technologies, Inc. (the “ Company Agreement Service Provider Technology, Services, and License

Note 4 - Financial Instruments

Note 4 - Financial Instruments	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Financial Instruments Disclosure [Text Block]	4. FINANCIAL INSTRUMENTS Assets and liabilities recorded at fair value on a recurring basis in the Consolidated Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: Level 1 Level 2 Level 3 The Company’s cash equivalent Money Market Funds and short-term investments consisting of US Treasury bill securities are classified as Level 1 because they are valued using quoted market prices. The following table shows the Company’s cash and cash equivalents, Money Market Funds and short-term investments by significant investment category as of December 31, 2022 and 2021. As of December 31, 2022 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 3,004 $ - $ - $ 3,004 US Treasury securities in short-term investments 9,849 100 - 9,949 Certificate of Deposits 4,000 - - 4,000 Total Financial Assets $ 16,853 $ 100 $ - $ 16,953 As of December 31, 2021 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 1,670 $ - $ - $ 1,670 US Treasury securities in short-term investments 29,989 - (6 ) 29,983 Total Financial Assets $ 31,659 $ - $ (6 ) $ 31,653 Unrealized gains or losses resulting from our short-term investments are recorded in accumulated other comprehensive gain or loss. During the year ended December 31, 2022 and 2021, $100 and $(21) was recorded to accumulated other comprehensive loss and gain, respectively. Our financial instruments also include accounts receivable, accounts payable, accrued liabilities and business acquisition liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheets.

Note 5 - Inventories, Net

Note 5 - Inventories, Net	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Inventory Disclosure [Text Block]	5. INVENTORIES, NET Inventory is recorded at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventories consisted of the following: December 31, 2022 2021 Finished goods $ 2,293 $ 1,027 Work in process - 2 Raw materials 1,682 537 Inventories - net $ 3,975 $ 1,566 As part of product line exit costs end of life raw material costs aggregating $621 were written off during the year ended December 31, 2021.

Note 6 - Property and Equipment

Note 6 - Property and Equipment, Net	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	6. PROPERTY AND EQUIPMENT, NET Property and equipment consisted of the following: December 31, 2022 2021 Production and lab equipment $ 513 $ 500 Tooling 448 273 Computer equipment 531 467 Furniture, fixtures and improvements 181 176 1,673 1,416 Accumulated depreciation (915 ) (440 ) Property and equipment, net $ 758 $ 976 Depreciation expense was $475 and $297 for the years ended December 31, 2022 and 2021, respectively. As part of product line exit costs unamortized production tooling costs of $106 were written off in the second quarter of 2021.

Note 7 - Intangible Assets, Net

Note 7 - Intangible Assets, Net	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	7. INTANGIBLE ASSETS, NET Intangible assets consisted of the following: December 31, 2022 2021 Amortizable intangible assets: Patents $ 575 $ 416 Trademarks 150 134 Purchased software 1,962 1,212 Other - 50 2,687 1,812 Accumulated amortization (462 ) (174 ) Total amortizable 2,225 1,638 Indefinite life assets (non-amortizable) 344 344 Total intangible assets, net $ 2,569 $ 1,982 Amortization expense was $287 and $182 for the years ended December 31, 2022 and 2021, respectively. An additional impairment charge of $170 for purchased software was recorded in the second quarter of 2021. At December 31, 2022, annual amortization of intangible assets, based upon the Company’s existing intangible assets and current useful lives, is estimated to be the following: 2023 $ 498 2024 518 2025 513 2026 212 2027 42 Thereafter 442 Total estimated amortization expense $ 2,225

Note 8 - Accounts Payable and A

Note 8 - Accounts Payable and Accrued Liabilities	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payable includes $127 and $228 due to related party Syzygy Licensing, LLC (“ Syzygy Accrued liabilities consist of the following: December 31, 2022 2021 Patent and legal costs $ 135 $ 28 Accrued compensation 1,100 628 Warranty costs 125 96 Taxes and other 103 72 $ 1,463 $ 824 Accrued compensation includes $1,022 and $305 in employee bonuses and commissions payable at December 31, 2022 and 2021, respectively. Changes in our estimated product warranty costs were as follows: Year Ended December 31, 2022 2021 Balance, beginning of period $ 96 $ 48 Warranty settlements (181 ) (62 ) Warranty provision 210 110 Balance, end of period $ 125 $ 96

Note 9 - Lease

Note 9 - Lease	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	9. LEASES The Company determines if an arrangement is a lease at inception. The guidance in FASB ASC Topic 842, Leases ( ROU For leases beginning on or after January 1, 2019 , Amortization of ROU operating lease assets was $101 and $88 for the years ended December 31, 2022 and 2021, respectively. Operating lease expense for capitalized operating leases included in operating activities was $118 and $95 for the years ended December 31, 2022 and 2021, respectively. Operating lease obligations recorded on the balance sheet at December 31, 2022 are: Operating lease liability- short term $ 108 Operating lease liability - long term 193 Total Operating Lease Liability $ 301 Future lease payments included in the measurement of lease liabilities on the balance sheet at December 31, 2022 for future periods are as follows: 2023 $ 121 2024 126 2025 75 Total future minimum lease payments 322 Less imputed interest (21 ) Total $ 301 The weighted average remaining lease term is 2.58 years, and the weighted average discount rate is 5.0%. Certain leases contain provisions for payment of real estate taxes, insurance and maintenance costs by the Company. These expenses are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred. The Company had $39 and $29 variable lease expenses during year ended December 31, 2022 or 2021. The Company had $11 and $0 short-term lease expense during year ended December 31, 2022, or 2021. The Company does not have any finance leases.

Note 10 - Debt

Note 10 - Debt	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	10. DEBT The Company’s debt at December 31, 2022 and 2021 included operating lease liabilities (see Note 9). The Company’s debt at December 31, 2021 also included business acquisition liabilities.

Note 11 - Stockholders' Equity

Note 11 - Stockholders' Equity	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	11. STOCKHOLDERS EQUITY The Company’s authorized capital consists of 150,000,000 shares of Common Stock, par value $0.0001 per share, and 5,000,000 shares of preferred stock, par value $0.0001 per share (“ Preferred Stock During the year ended December 31, 2021, the Company received proceeds of $12,047 from the exercise of 1,815,012 warrants. At December 31, 2021 the Company had outstanding Common Stock purchase warrants exercisable for 1,391,667 shares that expired on June 1, 2022, and had no purchase warrants outstanding at December 31, 2022.

Note 12 - Share-based Compensat

Note 12 - Share-based Compensation	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	12. SHARE-BASED COMPENSATION On March 31, 2017, the Company adopted, and the stockholders approved, the 2017 Stock Incentive Plan (the “ Plan The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan. The following table summarizes stock option activity for the year ended December 31, 2022: Weighted Average Options on Remaining Aggregate Common Exercise Contractual Intrinsic Shares Price Term Value Outstanding January 1, 2022 3,935,883 $ 5.24 4.79 Granted 4,153,885 $ 3.64 Exercised (55,500 ) $ 1.50 Forfeited, cancelled, expired (2,542,869 ) $ 5.79 Outstanding December 31, 2022 5,491,399 $ 3.72 5.96 $ 92 Exercisable December 31, 2022 2,465,110 $ 4.55 2.13 $ 92 At December 31, 2022, there were 3,877,169 service-based stock options outstanding, and 1,614,230 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s Chief Executive Officer and President, subject to future market capitalization targets. 1,049,145 of the 4,153,885 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant but are subject to the terms and conditions of the Plan. The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees: For the Year Ended December 31, 2022 2021 Expected stock price volatility 49 % 50 % Risk-free interest rate 2.47 % 0.90 % Forfeiture rate 0 % 0 % Expected dividend yield 0 % 0 % Expected life of options - years 5.96 5.74 Weighted-average fair value of options granted $ 0.88 $ 2.57 Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred. The risk-free interest rate assumption is based upon observed interest rates on zero coupon US Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of zero The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s newly appointed Chief Executive Officer and a newly appointed President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years. Stock option expense was $1,770 and $2,608 for the years ended December 31, 2022 and 2021, respectively. The following table summarizes information about stock options outstanding at December 31, 2022: Weighted Average Weighted Weighted Remaining Average Average Range of Number Contractual Exercise Number Exercise Exercise Prices Outstanding Life (Years) Price Exercisable Price $ 1.50 –2.27 820,750 0.39 $ 1.62 481,750 $ 1.50 $ 2.55 –3.83 876,409 0.87 $ 2.92 35,000 $ 3.61 $ 3.85 –5.78 2,050,010 2.19 $ 5.24 1,869,613 $ 5.28 $ 5.88 –8.82 130,000 6.25 $ 6.42 78,747 $ 6.36 Restricted Stock Units The Plan provides for the grant of restricted stock units (“ RSUs Weighted Average Weighted Average Service-Based Grant Date Vesting RSU's Fair Value Period (Years) Unvested at January 1, 2021 428,006 $ 6.13 2.3 Granted - service based 398,662 $ 5.59 Vested (524,491 ) $ 5.55 Forfeited and cancelled (32,874 ) $ 6.10 Unvested at December 31, 2021 269,303 $ 6.47 2.0 Granted - service based 988,850 $ 2.49 Vested (268,548 ) $ 4.13 Forfeited and cancelled (67,273 ) $ 6.45 Unvested at December 31, 2022 922,057 $ 2.88 2.11 A total of 175,173 RSUs included in the table above were granted in April 2022 outside the Plan as an employment inducement grant but are subject to the terms and conditions of the Plan. RSU expense was $1,455 and $2,748 for the years ended December 31, 2022 and 2021, respectively. Share-Based Compensation Expense The Company recorded share-based compensation in its statements of operations for the relevant periods for options and RSUs as follows: For the Year Ended December 31, 2022 2021 Selling, general and administrative $ 2,684 $ 4,558 Research and development 541 798 Total share-based expense $ 3,225 $ 5,356 As of December 31, 2022, total estimated compensation cost of stock options granted and outstanding but not yet vested was $3,327 which is expected to be recognized over the weighted average period of 3.38 years. As of December 31, 2022, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $1,900 which is expected to be recognized over the weighted average period of 2.11 years.

Note 13 - Defined Contribution

Note 13 - Defined Contribution Plan	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Defined Contribution Plan [Text Block]	13. DEFINED CONTRIBUTION PLAN The Company has a defined contribution savings plan for all eligible U.S. employees established under the provisions of Section 401(k) of the Internal Revenue Code. This plan was formed on January 1, 2022. Eligible employees may contribute a percentage of their salary subject to certain limitations. The Company’s contributions for the year ended December 31, 2022 was $0 respectively.

Note 14 - Commitments and Conti

Note 14 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	14. COMMITMENTS AND CONTINGENCIES Facility Lease See Note 9. Related Party Technology License Agreement The Company is obligated to pay royalties and development and patent costs pursuant to an exclusive Amended and Restated Intellectual Property License Agreement dated as of September 30, 2016, with Syzygy, a company owned and controlled by stockholder/consultant Mr. Elwood Norris and stockholder/consultant Mr. James Barnes. The agreement provides for royalty payments of 4% of revenue from products employing the licensed ensnarement device technology up to an aggregate of $1,000 in royalties or until September 30, 2026 , Service Provider Agreement Pursuant to the Professional Services and Technology Acquisition Agreement (the “ Agreement Service Provider Technology, Services, and License Purchase Commitments At December 31, 2022 the Company was committed for approximately $3,626 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business. Indemnifications and Guarantees Our officers and directors are indemnified as to personal liability as provided by the Delaware law and the Company’s articles and bylaws. The Company may also undertake indemnification obligations in the ordinary course of business related to its operations. The Company is unable to estimate with any reasonable accuracy the liability that may be incurred pursuant to any such indemnification obligations now or in the future. Because of the uncertainty surrounding these circumstances, the Company’s current or future indemnification obligations could range from immaterial to having a material adverse impact on its financial position and its ability to continue in the ordinary course of business. The Company has no liabilities recorded for such indemnities. Regulatory Agencies The Company is subject to oversight from regulatory agencies regarding firearms that arises in the ordinary course of its business. Litigation Securities Litigation On November 15, 2021, the Hon. Dolly M. Gee of the US District Court for the Central District of California (the “ Court Norris Barnes Smith Rothans Thomas In re Wrap Technologies, Inc. Securities Exchange Act Litigation Securities Action Shareholder Derivative Litigation On November 13, 2020, Naresh Rammohan filed a shareholder derivative action in the US District Court for the Central District of California against current and former Company officers as well as current and former Company directors alleging unjust enrichment, breach of fiduciary duty, waste of corporate assets, and contribution claims under the Securities Exchange Act of 1934, docketed as Case No. 2:20-cv-10444-DMG-PVCx. The derivative action was dismissed with prejudice by stipulation of the parties on May 3, 2022.

Note 15 - Related Party Transac

Note 15 - Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	15. RELATED PARTY TRANSACTIONS Commencing in October 2017 the Company began reimbursing Mr. Elwood Norris, a former officer and current stockholder and consultant of the Company, $1.5 per month on a month-to-month basis for laboratory facility expense, for an aggregate of $18 during the years months ended December 31, 2022, and 2021, respectively. Mr. Norris retired as the Company’s Chief Technology Officer effective June 30, 2021 and commencing July 1 was engaged as a month-to-month consultant. A greater than 10% stockholder, Mr. Norris was paid a monthly fee of $7.5 per month for aggregate consulting payments of $90 for the period ended December 31, 2022, and $45 for the six-month period ended December 31, 2021. See Notes 8 and 14 for additional information on related party transactions and obligations.

Note 16 - Income Taxes

Note 16 - Income Taxes	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	16. INCOME TAXES Until its reverse recapitalization on March 31, 2017, the Company was treated as a partnership for federal and state income tax purposes and did not incur income taxes. The Company accounts for income taxes under ASC 740. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Accounting standards require the consideration of a valuation allowance for deferred tax assets if it is "more likely than not" that some component or all of the benefits of deferred tax assets will not be realized. The Company did not provide any current or deferred US federal income tax provision or benefit for the periods presented because of operating losses since inception. As of December 31, 2022, the Company has federal net operating loss carryforwards of approximately $51,774 to reduce future taxable income. Approximately $703 will expire in 2037 with the balance having an indefinite carryforward period. Certain changes in stock ownership can result in a limitation on the amount of net operating loss and tax credit carryovers that can be utilized each year. As of December 31, 2022, management has not determined the extent of any such limitations, if any. The Company is subject to taxation in the US and various state jurisdictions. All the Company’s historical tax years are subject to examination by the Internal Revenue Service and various state jurisdictions due to the generation of net operating losses and credit carryforwards. The Company provided a full valuation allowance on the net deferred tax asset, consisting primarily of net operating loss carry forwards, because management has determined that it is more likely than not that the Company will not earn income sufficient to realize the deferred tax assets during the carry forward period. As a result of the change in future Federal statutory tax rates due to the passing of the Tax Cuts and Jobs Act of 2017, management determined that the deferred tax assets and liabilities should be valued at a federal statutory rate of 21%. The Company has not taken a tax position that, if challenged, would have a material effect on the financial statements for the periods ended December 31, 2022, and 2021 applicable under FASB ASC 740. The Company did not recognize any adjustment to the liability for uncertain tax position and therefore did not record any adjustment to the beginning balance of accumulated deficit on the balance sheet. The provision for (benefit from) income taxes consist of the following: Year Ended December 31, 2022 2021 Current tax benefit $ - $ - Deferred tax benefit 3,756 6,409 Change in valuation allowance (3,756 ) (6,409 ) Income tax benefit (provision) $ - $ - A reconciliation of the provision for income taxes at the federal statutory rate of 21% to the Company’s provision for income tax is as follows: Year Ended December 31, 2022 2021 Income taxes benefit computed at federal statutory rate $ 3,700 $ 5,139 State income taxes, net of federal effect 345 480 Permanent differences and other (289 ) 790 Change in valuation allowance (3,756 ) (6,409 ) Income tax benefit (provision) $ - $ - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table presents the significant components of the Company’s deferred tax assets and liabilities for the periods presented: December 31, 2022 2021 Deferred tax assets: Net operating losses $ 14,898 $ 11,773 Research tax credits 65 60 Stock compensation 1,216 847 Accruals and other 324 211 16,503 12,891 Deferred tax liabilities: Depreciation and other 534 678 534 678 Net deferred tax assets 15,969 12,213 Less valuation allowance (15,969 ) (12,213 ) Net deferred taxes after valuation allowance $ - $ - In accordance with ASU 2016-09, Compensation-Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting

Note 17 - Major Customers and R

Note 17 - Major Customers and Related Information	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	17. MAJOR CUSTOMERS AND RELATED INFORMATION Major Customers For the year ended December 31, 2022, revenues from two one For the year ended December 31, 2021, revenues from three The following table summarizes revenues by geographic region. Revenues are attributed to countries based on customer’s delivery location. For the Year Ended December 31, 2022 2021 Americas $ 5,315 $ 3,357 Europe, Middle East and Africa 2,487 2,385 Asia Pacific 247 1,987 Total revenues $ 8,049 $ 7,729 See Note 1 – Concentrations of Risks

Note 18 - Subsequent Events

Note 18 - Subsequent Events	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Subsequent Events [Text Block]	18. SUBSEQUENT EVENTS The Company has evaluated other events subsequent to December 31, 2022 through the date the accompanying financial statements were filed with the Securities and Exchange Commission and noted that there have been no other events or transactions which would affect the Company’s financial statements for the year ended December 31, 2022.

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Organization and Business Description [Policy Text Block]	Organization and Business Description Company we us our Common Stock Nasdaq
Consolidation, Policy [Policy Text Block]	Principles of Consolidation one VR
Use of Estimates, Policy [Policy Text Block]	Basis of Presentation and Use of Estimates US GAAP
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Risk Credit Risk Concentrations of Accounts Receivable and Revenue Concentration of Suppliers Impact of COVID-19 ( COVID-19
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents US
Investment, Policy [Policy Text Block]	Short-Term Investments
Share-Based Payment Arrangement [Policy Text Block]	Share-Based Compensation ASC 718 ASU
Earnings Per Share, Policy [Policy Text Block]	Loss per Share
Accounts Receivable [Policy Text Block]	Accounts Receivable and Allowance for Credit Losses Financial Instruments - Credit Losses (Topic 326) F-8 Table of Contents
Inventory, Policy [Policy Text Block]	Inventories .
Property, Plant and Equipment, Policy [Policy Text Block]	Property, Equipment and Depreciation
Business Combinations Policy [Policy Text Block]	Business Combinations
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Intangible Assets
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets
Classification and Valuation of Warrants [Policy Text Block]	Classification and Valuation of Warrants
Advertising Cost [Policy Text Block]	Advertising and Promotion Costs
Demonstration and Training Costs [Policy Text Block]	Demonstration and Training Costs
Research and Development Expense, Policy [Policy Text Block]	Research and Development Costs
Contract Manufacturers Policy [Policy Text Block]	Contract Manufacturers
Lessee, Leases [Policy Text Block]	Leases Topic 842
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition SSP SSPs
Shipping and Handling Costs [Policy Text Block]	Shipping and Handling Costs
Exit Activity Expenses [Policy Text Block]	Exit Activity Expense
Standard Product Warranty, Policy [Policy Text Block]	Warranty Reserves
Segment Reporting, Policy [Policy Text Block]	Segment Information
Income Tax, Policy [Policy Text Block]	Income Taxes
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Guidance , FASB ASU Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ASU 2021-08 ASC , Revenue from Contracts with Customers Topic 606 ,

Note 2 - Revenue and Product _2

Note 2 - Revenue and Product Costs (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	Customer Deferred Deposits Revenue Balance at January 1, 2022 $ 43 $ 265 Additions, net - 301 Transfer to revenue (43 ) (233 ) Balance at December 31, 2022 $ - $ 333 Current portion $ - $ 166 Long-term portion $ - $ 167

Note 4 - Financial Instruments

Note 4 - Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	As of December 31, 2022 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 3,004 $ - $ - $ 3,004 US Treasury securities in short-term investments 9,849 100 - 9,949 Certificate of Deposits 4,000 - - 4,000 Total Financial Assets $ 16,853 $ 100 $ - $ 16,953 As of December 31, 2021 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 1,670 $ - $ - $ 1,670 US Treasury securities in short-term investments 29,989 - (6 ) 29,983 Total Financial Assets $ 31,659 $ - $ (6 ) $ 31,653

Note 5 - Inventories, Net (Tabl

Note 5 - Inventories, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 2022 2021 Finished goods $ 2,293 $ 1,027 Work in process - 2 Raw materials 1,682 537 Inventories - net $ 3,975 $ 1,566

Note 6 - Property and Equipme_2

Note 6 - Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31, 2022 2021 Production and lab equipment $ 513 $ 500 Tooling 448 273 Computer equipment 531 467 Furniture, fixtures and improvements 181 176 1,673 1,416 Accumulated depreciation (915 ) (440 ) Property and equipment, net $ 758 $ 976

Note 7 - Intangible Assets, N_2

Note 7 - Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2022 2021 Amortizable intangible assets: Patents $ 575 $ 416 Trademarks 150 134 Purchased software 1,962 1,212 Other - 50 2,687 1,812 Accumulated amortization (462 ) (174 ) Total amortizable 2,225 1,638 Indefinite life assets (non-amortizable) 344 344 Total intangible assets, net $ 2,569 $ 1,982
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2023 $ 498 2024 518 2025 513 2026 212 2027 42 Thereafter 442 Total estimated amortization expense $ 2,225

Note 8 - Accounts Payable and_2

Note 8 - Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	December 31, 2022 2021 Patent and legal costs $ 135 $ 28 Accrued compensation 1,100 628 Warranty costs 125 96 Taxes and other 103 72 $ 1,463 $ 824
Schedule of Product Warranty Liability [Table Text Block]	Year Ended December 31, 2022 2021 Balance, beginning of period $ 96 $ 48 Warranty settlements (181 ) (62 ) Warranty provision 210 110 Balance, end of period $ 125 $ 96

Note 9 - Lease (Tables)

Note 9 - Lease (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Lessee, Operating Lease, Disclosure [Table Text Block]	Operating lease liability- short term $ 108 Operating lease liability - long term 193 Total Operating Lease Liability $ 301
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	2023 $ 121 2024 126 2025 75 Total future minimum lease payments 322 Less imputed interest (21 ) Total $ 301

Note 12 - Share-based Compens_2

Note 12 - Share-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Average Options on Remaining Aggregate Common Exercise Contractual Intrinsic Shares Price Term Value Outstanding January 1, 2022 3,935,883 $ 5.24 4.79 Granted 4,153,885 $ 3.64 Exercised (55,500 ) $ 1.50 Forfeited, cancelled, expired (2,542,869 ) $ 5.79 Outstanding December 31, 2022 5,491,399 $ 3.72 5.96 $ 92 Exercisable December 31, 2022 2,465,110 $ 4.55 2.13 $ 92
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	For the Year Ended December 31, 2022 2021 Expected stock price volatility 49 % 50 % Risk-free interest rate 2.47 % 0.90 % Forfeiture rate 0 % 0 % Expected dividend yield 0 % 0 % Expected life of options - years 5.96 5.74 Weighted-average fair value of options granted $ 0.88 $ 2.57
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Weighted Average Weighted Weighted Remaining Average Average Range of Number Contractual Exercise Number Exercise Exercise Prices Outstanding Life (Years) Price Exercisable Price $ 1.50 –2.27 820,750 0.39 $ 1.62 481,750 $ 1.50 $ 2.55 –3.83 876,409 0.87 $ 2.92 35,000 $ 3.61 $ 3.85 –5.78 2,050,010 2.19 $ 5.24 1,869,613 $ 5.28 $ 5.88 –8.82 130,000 6.25 $ 6.42 78,747 $ 6.36
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Weighted Average Weighted Average Service-Based Grant Date Vesting RSU's Fair Value Period (Years) Unvested at January 1, 2021 428,006 $ 6.13 2.3 Granted - service based 398,662 $ 5.59 Vested (524,491 ) $ 5.55 Forfeited and cancelled (32,874 ) $ 6.10 Unvested at December 31, 2021 269,303 $ 6.47 2.0 Granted - service based 988,850 $ 2.49 Vested (268,548 ) $ 4.13 Forfeited and cancelled (67,273 ) $ 6.45 Unvested at December 31, 2022 922,057 $ 2.88 2.11
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]	For the Year Ended December 31, 2022 2021 Selling, general and administrative $ 2,684 $ 4,558 Research and development 541 798 Total share-based expense $ 3,225 $ 5,356

Note 16 - Income Taxes (Tables)

Note 16 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Year Ended December 31, 2022 2021 Current tax benefit $ - $ - Deferred tax benefit 3,756 6,409 Change in valuation allowance (3,756 ) (6,409 ) Income tax benefit (provision) $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Year Ended December 31, 2022 2021 Income taxes benefit computed at federal statutory rate $ 3,700 $ 5,139 State income taxes, net of federal effect 345 480 Permanent differences and other (289 ) 790 Change in valuation allowance (3,756 ) (6,409 ) Income tax benefit (provision) $ - $ -
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, 2022 2021 Deferred tax assets: Net operating losses $ 14,898 $ 11,773 Research tax credits 65 60 Stock compensation 1,216 847 Accruals and other 324 211 16,503 12,891 Deferred tax liabilities: Depreciation and other 534 678 534 678 Net deferred tax assets 15,969 12,213 Less valuation allowance (15,969 ) (12,213 ) Net deferred taxes after valuation allowance $ - $ -

Note 17 - Major Customers and_2

Note 17 - Major Customers and Related Information (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the Year Ended December 31, 2022 2021 Americas $ 5,315 $ 3,357 Europe, Middle East and Africa 2,487 2,385 Asia Pacific 247 1,987 Total revenues $ 8,049 $ 7,729

Note 1 - Organization and Sum_2

Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001	$ 0.0001
Number of Wholly-owned Subsidiaries	1
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares	6,413,546	5,596,853
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 205	$ 134
Inventory Valuation Reserves	0	0
Advertising Expense	426	145
Marketing Expense	688	924
Cost of Revenue, Total	4,315	5,734
Revenue from Contract with Customer, Including Assessed Tax	7,481	7,381
Product Line Exit Expense	0	747
Write-off, Inventory Cost		641
Retiring Cost		106
Standard Product Warranty Accrual, Ending Balance	125	96
Shipping and Handling [Member]
Cost of Revenue, Total	296	167
Revenue from Contract with Customer, Including Assessed Tax	$ 109	$ 88

Note 2 - Revenue and Product _3

Note 2 - Revenue and Product Costs (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Contract with Customer, Liability, Total	$ 333	$ 265
Contract with Customer, Asset, after Allowance for Credit Loss, Total	0	0
Virtual Reality Training [Member]
Contract with Customer, Liability, Total	198	172
Training [Member]
Contract with Customer, Liability, Total	11
Extended Product Warranties [Member]
Contract with Customer, Liability, Total	$ 124	$ 67

Note 2 - Revenue and Product _4

Note 2 - Revenue and Product Costs - Contract Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Balance	$ 265
Balance	333
Current portion	166	$ 155
Long-term portion	167	$ 110
Customer Deposits [Member]
Balance	43
Additions, net	0
Transfer to revenue	(43)
Balance	0
Current portion	0
Long-term portion	0
Deferred Revenue [Member]
Balance	265
Additions, net	301
Transfer to revenue	(233)
Balance	333
Current portion	166
Long-term portion	$ 167

Note 3 - Asset Acquisition (Det

Note 3 - Asset Acquisition (Details Textual) - Professional Services and Technology Acquisition Agreement [Member] - USD ($) $ in Thousands		12 Months Ended
	Nov. 22, 2022	Dec. 31, 2022
Payments to Acquire Businesses, Gross	$ 700	$ 700
Finite-Lived Intangible Assets Acquired	$ 700
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	3 years
February 13 Delviery [Member]
Business Combination, Contingent Consideration, Liability, Total	$ 125	125
Final Delivery of Technology, Services, and License [Member]
Business Combination, Contingent Consideration, Liability, Total	$ 125	$ 125

Note 4 - Financial Instrument_2

Note 4 - Financial Instruments (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$ 100	$ (21)

Note 4 - Financial Instrument_3

Note 4 - Financial Instruments - Instruments by Significant Investment Category (Details) - Fair Value, Inputs, Level 1 [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Adjusted cost	$ 16,853	$ 31,659
Unrealized gains	100	0
Unrealized losses	0	(6)
Market value	16,953	31,653
Money Market Funds [Member]
Adjusted cost	3,004	1,670
Unrealized gains	0	0
Unrealized losses	0	0
Market value	3,004	1,670
US Treasury Securities Considered Cash Equivalents [Member]
Adjusted cost	9,849	29,989
Unrealized gains	100	0
Unrealized losses	0	(6)
Market value	9,949	$ 29,983
Certificates of Deposit [Member]
Adjusted cost	4,000
Unrealized gains	0
Unrealized losses	0
Market value	$ 4,000

Note 5 - Inventories, Net (Deta

Note 5 - Inventories, Net (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($)
Product Line Exit Costs [Member]
Inventory Write-down	$ 621

Note 5 - Inventories, Net - Sum

Note 5 - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Finished goods		$ 2,293	$ 1,027
Work in process		0	2
Raw materials		1,682	537
Inventories - net	$ 3,975	$ 3,975	$ 1,566

Note 6 - Property and Equipme_3

Note 6 - Property and Equipment, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Depreciation, Total		$ 475	$ 297
Production Costs, Period Cost	$ 106

Note 6 - Property and Equipme_4

Note 6 - Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Property and equipment, gross	$ 1,673	$ 1,416
Accumulated depreciation	(915)	(440)
Property and equipment, net	758	976
Production and Lab Equipment [Member]
Property and equipment, gross	513	500
Tooling [Member]
Property and equipment, gross	448	273
Computer Equipment [Member]
Property and equipment, gross	531	467
Furniture and Fixtures [Member]
Property and equipment, gross	$ 181	$ 176

Note 7 - Intangible Assets, N_3

Note 7 - Intangible Assets, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Amortization of Intangible Assets		$ 287	$ 182
Impairment, Long-Lived Asset, Held-for-Use, Total	$ 170

Note 7 - Intangible Assets, N_4

Note 7 - Intangible Assets, Net - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Amortizable intangible assets, gross	$ 2,687	$ 1,812
Accumulated amortization	(462)	(174)
Total amortizable	2,225	1,638
Indefinite life assets (non-amortizable)	344	344
Total intangible assets, net	2,569	1,982
Patents [Member]
Amortizable intangible assets, gross	575	416
Trademarks [Member]
Amortizable intangible assets, gross	150	134
Computer Software, Intangible Asset [Member]
Amortizable intangible assets, gross	1,962	1,212
Other Intangible Assets [Member]
Amortizable intangible assets, gross	$ 0	$ 50

Note 7 - Intangible Assets, N_5

Note 7 - Intangible Assets, Net - Future Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
2023	$ 498
2024	518
2025	513
2026	212
2027	42
Thereafter	442
Total amortizable	$ 2,225	$ 1,638

Note 8 - Accounts Payable and_3

Note 8 - Accounts Payable and Accrued Liabilities (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Commissions Payable [Member]
Employee-related Liabilities, Total	$ 1,022	$ 305
Syzygy Licensing LLC [Member]
Accounts Payable, Total	$ 127	$ 228

Note 8 - Accounts Payable and_4

Note 8 - Accounts Payable and Accrued Liabilities - Summary of Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Patent and legal costs	$ 135	$ 28
Accrued compensation	1,100	628
Warranty costs	125	96
Taxes and other	103	72
Accrued Liabilities, Current, Total	$ 1,463	$ 824

Note 8 - Accounts Payable and_5

Note 8 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Balance	$ 96	$ 48
Warranty settlements	(181)	(62)
Warranty provision	210	110
Balance	$ 125	$ 96

Note 9 - Lease (Details Textual

Note 9 - Lease (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Lease, Right-of-Use Asset, Amortization Expense	$ 101,000	$ 88,000
Operating Lease, Expense	$ 118,000	95,000
Operating Lease, Weighted Average Remaining Lease Term	2 years 6 months 29 days
Operating Lease, Weighted Average Discount Rate, Percent	5%
Variable Lease, Cost	$ 39,000	29,000
Short-Term Lease, Cost	$ 11	$ 0

Note 9 - Lease - Summary of Ope

Note 9 - Lease - Summary of Operating Lease Obligations (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Operating lease liability - short term	$ 108	$ 56
Operating lease liability - long term	193	$ 0
Total Operating Lease Liability	$ 301

Note 9 - Lease - Future Lease P

Note 9 - Lease - Future Lease Payments (Details) $ in Thousands	Dec. 31, 2022 USD ($)
2023	$ 121
2024	126
2025	75
Total future minimum lease payments	322
Less imputed interest	(21)
Total	$ 301

Note 11 - Stockholders' Equity

Note 11 - Stockholders' Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Common Stock, Shares Authorized	150,000,000	150,000,000
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Proceeds from Warrant Exercises	$ 0	$ 12,047
Class of Warrant or Right, Exercised During Period		1,815,012
Class of Warrant or Right, Outstanding	0	1,391,667

Note 12 - Share-based Compens_3

Note 12 - Share-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended						12 Months Ended
	Jun. 30, 2022	Apr. 30, 2022	Jan. 31, 2022	Jun. 30, 2021	Jun. 30, 2020	May 31, 2019	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2017
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance							5,491,399	3,935,883
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross							4,153,885
Share-Based Payment Arrangement, Expense							$ 3,225	$ 5,356
Employment Inducement Grant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		1,049,145
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross							4,153,885
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate							0%	0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term							5 years 11 months 15 days	5 years 8 months 26 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate							49%	50%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate							2.47%	0.90%
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount							$ 3,327
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition							3 years 4 months 17 days
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		175,173					988,850	398,662
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount							$ 1,900
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition							2 years 1 month 9 days
The 2017 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized	9,000,000								2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized	1,500,000			1,500,000	1,900,000	2,100,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant							1,556,291
Share-Based Payment Arrangement, Accelerated Cost			$ 242
The 2017 Stock Incentive Plan [Member] | Service-based Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance							3,877,169
The 2017 Stock Incentive Plan [Member] | Performance-based Options [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Ending Balance							1,614,230
The 2017 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Expense							$ 1,770	$ 2,608
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		1,614,230
Share Price		$ 2.89
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term		10 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		49%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		2.90%
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period		4 years
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period		7 years
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		$ 250,000
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		500,000
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		$ 1,000,000
The 2017 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expense							$ 1,455	$ 2,748

Note 12 - Share-based Compens_4

Note 12 - Share-based Compensation - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Options on Common Shares, Outstanding (in shares)	3,935,883
Outstanding, weighted average exercise price (in dollars per share)	$ 5.24
Outstanding, remaining contractual term (Year)	5 years 11 months 15 days	4 years 9 months 14 days
Options on Common Shares, Granted (in shares)	4,153,885
Granted, weighted average exercise price (in dollars per share)	$ 3.64
Options on Common Shares, Exercised (in shares)	(55,500)
Exercised, weighted average exercise price (in dollars per share)	$ 1.50
Options on Common Shares, Forfeited, cancelled, expired (in shares)	(2,542,869)
Forfeited, cancelled, expired, weighted average exercise price (in dollars per share)	$ 5.79
Options on Common Shares, Outstanding (in shares)	5,491,399	3,935,883
Outstanding, weighted average exercise price (in dollars per share)	$ 3.72	$ 5.24
Outstanding, aggregate intrinsic value	$ 92
Exercisable, shares (in shares)	2,465,110
Exercisable, weighted average exercise price (in dollars per share)	$ 4.55
Exercisable, weighted average contractual term (Year)	2 years 1 month 17 days
Exercisable, aggregate intrinsic value	$ 92

Note 12 - Share-based Compens_5

Note 12 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Forfeiture rate	0%	0%
Weighted-average fair value of options granted (in dollars per share)	$ 0.88	$ 2.57
Share-Based Payment Arrangement, Option [Member]
Expected stock price volatility	49%	50%
Risk-free interest rate	2.47%	0.90%
Expected dividend yield	0%	0%
Expected life of options - years (Year)	5 years 11 months 15 days	5 years 8 months 26 days

Note 12 - Share-based Compens_6

Note 12 - Share-based Compensation - Information Regarding Stock Options Outstanding (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Exercise Price Range One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)	$ 1.50
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)	$ 2.27
Number outstanding (in shares) | shares	820,750
Options outstanding, weighted average remaining contractual term (Year)	4 months 20 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 1.62
Options exercisable, number of shares (in shares) | shares	481,750
Options exercisable, weighted average exercise price (in dollars per share)	$ 1.50
Exercise Price Range Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)	2.55
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)	$ 3.83
Number outstanding (in shares) | shares	876,409
Options outstanding, weighted average remaining contractual term (Year)	10 months 13 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 2.92
Options exercisable, number of shares (in shares) | shares	35,000
Options exercisable, weighted average exercise price (in dollars per share)	$ 3.61
Exercise Price Range Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)	3.85
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)	$ 5.78
Number outstanding (in shares) | shares	2,050,010
Options outstanding, weighted average remaining contractual term (Year)	2 years 2 months 8 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 5.24
Options exercisable, number of shares (in shares) | shares	1,869,613
Options exercisable, weighted average exercise price (in dollars per share)	$ 5.28
Exercise Price Range Four [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)	5.88
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)	$ 8.82
Number outstanding (in shares) | shares	130,000
Options outstanding, weighted average exercise price (in dollars per share)	$ 6.42
Options exercisable, number of shares (in shares) | shares	78,747
Options exercisable, weighted average exercise price (in dollars per share)	$ 6.36

Note 12 - Share-based Compens_7

Note 12 - Share-based Compensation - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	1 Months Ended	12 Months Ended
	Apr. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Awards other than options, unvested (in shares)		269,303	428,006
Awards other than options, unvested, weighted average grant date fair value (in dollars per share)		$ 6.47	$ 6.13
Unvested, vesting period (Year)		2 years 1 month 9 days	2 years	2 years 3 months 18 days
Awards other than options, Granted (in shares)	175,173	988,850	398,662
Awards other than options, granted, weighted average grant date fair value (in dollars per share)		$ 2.49	$ 5.59
Awards other than options, Vested (in shares)			(524,491)
Awards other than options, vested, weighted average grant date fair value (in dollars per share)		$ 4.13	$ 5.55
Awards other than options, Forfeited and cancelled (in shares)		(67,273)	(32,874)
Awards other than options, forfeited and cancelled, weighted average grant date fair value (in dollars per share)		$ 6.45	$ 6.10
Awards other than options, unvested (in shares)		922,057	269,303	428,006
Awards other than options, unvested, weighted average grant date fair value (in dollars per share)		$ 2.88	$ 6.47	$ 6.13

Note 12 - Share-based Compens_8

Note 12 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-based expense	$ 3,225	$ 5,356
Selling, General and Administrative Expenses [Member]
Share-based expense	2,684	4,558
Research and Development Expense [Member]
Share-based expense	$ 541	$ 798

Note 13 - Defined Contributio_2

Note 13 - Defined Contribution Plan (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Defined Benefit Plan, Plan Assets, Contributions by Employer	$ 0

Note 14 - Commitments and Con_2

Note 14 - Commitments and Contingencies (Details Textual) - USD ($)		12 Months Ended
	Nov. 22, 2022	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2016
Contractual Obligation, Total		$ 3,626,000
Professional Services and Technology Acquisition Agreement [Member]
Payments to Acquire Businesses, Gross	$ 700,000	700,000
Professional Services and Technology Acquisition Agreement [Member] | February 13 Delviery [Member]
Business Combination, Contingent Consideration, Liability, Total	125,000	125,000
Professional Services and Technology Acquisition Agreement [Member] | Final Delivery of Technology, Services, and License [Member]
Business Combination, Contingent Consideration, Liability, Total	$ 125,000	125,000
Related Party Technology License Agreement [Member] | Syzygy Licensing LLC [Member]
Royalty Payments, Percentage of Product Revenue				4%
Maximum Royalties to Be Paid Under Agreement				$ 1,000
Royalty Expense		274,000	$ 278,000
Royalty Guarantees, Commitments, Amount		$ 280,000

Note 15 - Related Party Trans_2

Note 15 - Related Party Transactions (Details Textual) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Related Party Transaction, Amounts of Transaction		$ 18,000	$ 18,000
Mr. Elwood Norris [Member]
Reimbursement of Expenses to Related Party, Monthly Amount		1,500
Consulting Fees to Related Party, Monthly Amount		7,500
Mr. Elwood Norris [Member] | Consultant [Member]
Related Party Transaction, Amounts of Transaction	$ 45,000	$ 90,000

Note 16 - Income Taxes (Details

Note 16 - Income Taxes (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Loss Carryforward Subject to Expiration	$ 703
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21%
Domestic Tax Authority [Member]
Operating Loss Carryforwards	$ 51,774
Operating Loss Carryforwards, Tax Deductions From Stock Options Exercises and RSU Vesting	597	$ 3,168
State and Local Jurisdiction [Member]
Operating Loss Carryforwards, Tax Deductions From Stock Options Exercises and RSU Vesting	$ 597	$ 3,168

Note 16 - Income Taxes - Income

Note 16 - Income Taxes - Income Tax Expense (Benefits) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Current tax benefit	$ 0	$ 0
Deferred tax benefit	3,756	6,409
Change in valuation allowance	(3,756)	(6,409)
Income tax benefit (provision)	$ 0	$ 0

Note 16 - Reconciliations of Fe

Note 16 - Reconciliations of Federal Statutory Rate to Effective Income Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income taxes benefit computed at federal statutory rate	$ 3,700	$ 5,139
State income taxes, net of federal effect	345	480
Permanent differences and other	(289)	790
Change in valuation allowance	(3,756)	(6,409)
Income tax benefit (provision)	$ 0	$ 0

Note 16 - Income Taxes - Deferr

Note 16 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Net operating losses	$ 14,898	$ 11,773
Research tax credits	65	60
Stock compensation	1,216	847
Accruals and other	324	211
Deferred Tax Assets, Gross, Total	16,503	12,891
Depreciation and other	534	678
Deferred Tax Liabilities, Gross, Total	534	678
Net deferred tax assets	15,969	12,213
Less valuation allowance	(15,969)	(12,213)
Net deferred taxes after valuation allowance	$ 0	$ 0

Note 17 - Major Customers and_3

Note 17 - Major Customers and Related Information (Details Textual) - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue Benchmark [Member] | Distributors [Member]
Number of Major Customers	2	3
Revenue Benchmark [Member] | Distributor One [Member]
Concentration Risk, Percentage	36%	26%
Revenue Benchmark [Member] | Distributor Two [Member]
Concentration Risk, Percentage	25%	19%
Revenue Benchmark [Member] | Distributor Three [Member]
Concentration Risk, Percentage		17%
Accounts Receivable [Member] | Distributors [Member]
Number of Major Customers	2
Accounts Receivable [Member] | Distributor One [Member]
Concentration Risk, Percentage	70%	48%
Accounts Receivable [Member] | Distributor Two [Member]
Concentration Risk, Percentage		16%
Accounts Receivable [Member] | Distributor Three [Member]
Concentration Risk, Percentage		15%

Note 17 - Major Customers and_4

Note 17 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Americas	$ 8,049	$ 7,729	$ 8,049	$ 7,729
Americas [Member]
Americas	5,315	3,357
Europe, Middle East and Africa [Member]
Americas	2,487	2,385
Asia Pacific [Member]
Americas	$ 247	$ 1,987